HRMY

Harmony Biosciences Holdings, Inc. Common Stock

36.51

USD

HRMY Earnings Reports

Positive Surprise Ratio

HRMY beat 15 of 21 last estimates.

71%

Next Report

Date of Next Report

Feb 23, 2026

Estimate for Q4 25 (Revenue/ EPS)

$244.31M

$0.93

Implied change from Q3 25 (Revenue/ EPS)

+2.03%

+6.90%

Implied change from Q4 24 (Revenue/ EPS)

+21.39%

+9.41%

Harmony Biosciences Holdings, Inc. Common Stock earnings per share and revenue

On Nov 04, 2025, HRMY reported earnings of 0.87 USD per share (EPS) for Q3 25, beating the estimate of 0.85 USD, resulting in a 1.62% surprise. Revenue reached 239.46 million, compared to an expected 228.15 million, with a 4.95% difference. The market reacted with a +4.74% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 13 analysts forecast an EPS of 0.93 USD, with revenue projected to reach 244.31 million USD, implying an increase of 6.90% EPS, and increase of 2.03% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Regeneron Pharmaceuticals Inc

Report Date

Jan 30, 2026 For Q4 25

Estimate

$10.84

Actual

$11.44

Surprise

+5.52%

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

FAQ

What were Harmony Biosciences Holdings, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Harmony Biosciences Holdings, Inc. Common Stock reported EPS of $0.87, beating estimates by 1.62%, and revenue of $239.46M, 4.95% above expectations.

How did the market react to Harmony Biosciences Holdings, Inc. Common Stock's Q3 2025 earnings?

The stock price moved up 4.74%, changed from $29.33 before the earnings release to $30.72 the day after.

When is Harmony Biosciences Holdings, Inc. Common Stock expected to report next?

The next earning report is scheduled for Feb 23, 2026.

What are the forecasts for Harmony Biosciences Holdings, Inc. Common Stock's next earnings report?

Based on 13 analysts, Harmony Biosciences Holdings, Inc. Common Stock is expected to report EPS of $0.93 and revenue of $244.31M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.